CVS HEALTH CORP (1CVS.MI) Fundamental Analysis & Valuation
BIT:1CVS • US1266501006
Current stock price
67.05 EUR
+0.64 (+0.96%)
Last:
This 1CVS.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 1CVS.MI Profitability Analysis
1.1 Basic Checks
- 1CVS had positive earnings in the past year.
- 1CVS had a positive operating cash flow in the past year.
- In the past 5 years 1CVS has always been profitable.
- Each year in the past 5 years 1CVS had a positive operating cash flow.
1.2 Ratios
- 1CVS has a Return On Assets of 0.70%. This is in the lower half of the industry: 1CVS underperforms 66.67% of its industry peers.
- 1CVS's Return On Equity of 2.35% is on the low side compared to the rest of the industry. 1CVS is outperformed by 63.64% of its industry peers.
- 1CVS has a Return On Invested Capital of 4.90%. This is in the lower half of the industry: 1CVS underperforms 60.61% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for 1CVS is in line with the industry average of 6.44%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.7% | ||
| ROE | 2.35% | ||
| ROIC | 4.9% |
ROA(3y)1.95%
ROA(5y)2.24%
ROE(3y)6.46%
ROE(5y)7.21%
ROIC(3y)5.46%
ROIC(5y)6.31%
1.3 Margins
- The Profit Margin of 1CVS (0.44%) is worse than 66.67% of its industry peers.
- 1CVS's Profit Margin has declined in the last couple of years.
- The Operating Margin of 1CVS (2.58%) is worse than 75.76% of its industry peers.
- In the last couple of years the Operating Margin of 1CVS has declined.
- Looking at the Gross Margin, with a value of 13.77%, 1CVS is doing worse than 63.64% of the companies in the same industry.
- In the last couple of years the Gross Margin of 1CVS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.58% | ||
| PM (TTM) | 0.44% | ||
| GM | 13.77% |
OM growth 3Y-19.74%
OM growth 5Y-12.87%
PM growth 3Y-30.97%
PM growth 5Y-30.29%
GM growth 3Y-6.6%
GM growth 5Y-5.48%
2. 1CVS.MI Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1CVS is destroying value.
- The number of shares outstanding for 1CVS has been increased compared to 1 year ago.
- The number of shares outstanding for 1CVS has been reduced compared to 5 years ago.
- The debt/assets ratio for 1CVS has been reduced compared to a year ago.
2.2 Solvency
- 1CVS has an Altman-Z score of 2.32. This is not the best score and indicates that 1CVS is in the grey zone with still only limited risk for bankruptcy at the moment.
- The Altman-Z score of 1CVS (2.32) is better than 69.70% of its industry peers.
- The Debt to FCF ratio of 1CVS is 8.27, which is on the high side as it means it would take 1CVS, 8.27 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 8.27, 1CVS is in line with its industry, outperforming 57.58% of the companies in the same industry.
- A Debt/Equity ratio of 0.80 indicates that 1CVS is somewhat dependend on debt financing.
- With a Debt to Equity ratio value of 0.80, 1CVS perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.8 | ||
| Debt/FCF | 8.27 | ||
| Altman-Z | 2.32 |
ROIC/WACC0.63
WACC7.75%
2.3 Liquidity
- 1CVS has a Current Ratio of 0.84. This is a bad value and indicates that 1CVS is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Current ratio value of 0.84, 1CVS is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
- A Quick Ratio of 0.63 indicates that 1CVS may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.63, 1CVS is doing worse than 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.63 |
3. 1CVS.MI Growth Analysis
3.1 Past
- 1CVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.54%, which is quite impressive.
- The Earnings Per Share has been decreasing by -2.11% on average over the past years.
- 1CVS shows a small growth in Revenue. In the last year, the Revenue has grown by 7.85%.
- The Revenue has been growing by 8.39% on average over the past years. This is quite good.
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
Revenue 1Y (TTM)7.85%
Revenue growth 3Y7.63%
Revenue growth 5Y8.39%
Sales Q2Q%8.17%
3.2 Future
- The Earnings Per Share is expected to grow by 9.08% on average over the next years. This is quite good.
- Based on estimates for the next years, 1CVS will show a small growth in Revenue. The Revenue will grow by 4.27% on average per year.
EPS Next Y7.28%
EPS Next 2Y10.96%
EPS Next 3Y11.47%
EPS Next 5Y9.08%
Revenue Next Year1.49%
Revenue Next 2Y3.12%
Revenue Next 3Y3.88%
Revenue Next 5Y4.27%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. 1CVS.MI Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 11.40, the valuation of 1CVS can be described as very reasonable.
- Based on the Price/Earnings ratio, 1CVS is valued cheaper than 84.85% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 25.23. 1CVS is valued rather cheaply when compared to this.
- The Price/Forward Earnings ratio is 10.64, which indicates a very decent valuation of 1CVS.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of 1CVS indicates a rather cheap valuation: 1CVS is cheaper than 81.82% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 23.28, 1CVS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.4 | ||
| Fwd PE | 10.64 |
4.2 Price Multiples
- 1CVS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.53 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- 1CVS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.57
PEG (5Y)N/A
EPS Next 2Y10.96%
EPS Next 3Y11.47%
5. 1CVS.MI Dividend Analysis
5.1 Amount
- 1CVS has a Yearly Dividend Yield of 3.70%. Purely for dividend investing, there may be better candidates out there.
- 1CVS's Dividend Yield is rather good when compared to the industry average which is at 1.69. 1CVS pays more dividend than 90.91% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.91, 1CVS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.7% |
5.2 History
- The dividend of 1CVS has a limited annual growth rate of 5.96%.
Dividend Growth(5Y)5.96%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
- 1CVS pays out 192.14% of its income as dividend. This is not a sustainable payout ratio.
- 1CVS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP192.14%
EPS Next 2Y10.96%
EPS Next 3Y11.47%
1CVS.MI Fundamentals: All Metrics, Ratios and Statistics
BIT:1CVS (3/13/2026, 7:00:00 PM)
67.05
+0.64 (+0.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-10 2026-02-10/bmo
Earnings (Next)04-29 2026-04-29/bmo
Inst Owners90.76%
Inst Owner ChangeN/A
Ins Owners0.98%
Ins Owner ChangeN/A
Market Cap85.30B
Revenue(TTM)402.07B
Net Income(TTM)1.77B
Analysts79.39
Price Target81.48 (21.52%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.7% |
Yearly Dividend2.32
Dividend Growth(5Y)5.96%
DP192.14%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.24%
Min EPS beat(2)8.8%
Max EPS beat(2)15.69%
EPS beat(4)4
Avg EPS beat(4)19.56%
Min EPS beat(4)8.8%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)7.29%
EPS beat(12)10
Avg EPS beat(12)6.2%
EPS beat(16)14
Avg EPS beat(16)5.76%
Revenue beat(2)2
Avg Revenue beat(2)2.03%
Min Revenue beat(2)1.02%
Max Revenue beat(2)3.04%
Revenue beat(4)4
Avg Revenue beat(4)1.93%
Min Revenue beat(4)0.02%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.75%
Revenue beat(12)9
Avg Revenue beat(12)1.31%
Revenue beat(16)13
Avg Revenue beat(16)2.17%
PT rev (1m)0%
PT rev (3m)14.72%
EPS NQ rev (1m)-0.56%
EPS NQ rev (3m)-3.19%
EPS NY rev (1m)0%
EPS NY rev (3m)0.01%
Revenue NQ rev (1m)-1.96%
Revenue NQ rev (3m)-3.01%
Revenue NY rev (1m)-1.1%
Revenue NY rev (3m)-0.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.4 | ||
| Fwd PE | 10.64 | ||
| P/S | 0.24 | ||
| P/FCF | 12.53 | ||
| P/OCF | 9.19 | ||
| P/B | 1.3 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)5.88
EY8.77%
EPS(NY)6.3
Fwd EY9.4%
FCF(TTM)5.35
FCFY7.98%
OCF(TTM)7.29
OCFY10.88%
SpS275.68
BVpS51.57
TBVpS-24.53
PEG (NY)1.57
PEG (5Y)N/A
Graham Number82.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.7% | ||
| ROE | 2.35% | ||
| ROCE | 6.3% | ||
| ROIC | 4.9% | ||
| ROICexc | 5.23% | ||
| ROICexgc | 18.66% | ||
| OM | 2.58% | ||
| PM (TTM) | 0.44% | ||
| GM | 13.77% | ||
| FCFM | 1.94% |
ROA(3y)1.95%
ROA(5y)2.24%
ROE(3y)6.46%
ROE(5y)7.21%
ROIC(3y)5.46%
ROIC(5y)6.31%
ROICexc(3y)5.85%
ROICexc(5y)6.83%
ROICexgc(3y)22.7%
ROICexgc(5y)25.24%
ROCE(3y)7.06%
ROCE(5y)8.13%
ROICexgc growth 3Y-15.72%
ROICexgc growth 5Y-3.91%
ROICexc growth 3Y-15.74%
ROICexc growth 5Y-5.12%
OM growth 3Y-19.74%
OM growth 5Y-12.87%
PM growth 3Y-30.97%
PM growth 5Y-30.29%
GM growth 3Y-6.6%
GM growth 5Y-5.48%
F-Score6
Asset Turnover1.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.8 | ||
| Debt/FCF | 8.27 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.7% | ||
| Interest Coverage | -3.47 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 441.57% | ||
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.63 | ||
| Altman-Z | 2.32 |
F-Score6
WACC7.75%
ROIC/WACC0.63
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.77%
Cap/Sales(5y)0.8%
Profit Quality(3y)234.42%
Profit Quality(5y)242.41%
High Growth Momentum
Growth
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
EPS Next Y7.28%
EPS Next 2Y10.96%
EPS Next 3Y11.47%
EPS Next 5Y9.08%
Revenue 1Y (TTM)7.85%
Revenue growth 3Y7.63%
Revenue growth 5Y8.39%
Sales Q2Q%8.17%
Revenue Next Year1.49%
Revenue Next 2Y3.12%
Revenue Next 3Y3.88%
Revenue Next 5Y4.27%
EBIT growth 1Y6.02%
EBIT growth 3Y-13.61%
EBIT growth 5Y-5.55%
EBIT Next Year23.87%
EBIT Next 3Y14.96%
EBIT Next 5YN/A
FCF growth 1Y23.41%
FCF growth 3Y-16.58%
FCF growth 5Y-10.28%
OCF growth 1Y16.82%
OCF growth 3Y-13.04%
OCF growth 5Y-7.68%
CVS HEALTH CORP / 1CVS.MI Fundamental Analysis FAQ
What is the fundamental rating for 1CVS stock?
ChartMill assigns a fundamental rating of 4 / 10 to 1CVS.MI.
What is the valuation status of CVS HEALTH CORP (1CVS.MI) stock?
ChartMill assigns a valuation rating of 5 / 10 to CVS HEALTH CORP (1CVS.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for CVS HEALTH CORP?
CVS HEALTH CORP (1CVS.MI) has a profitability rating of 2 / 10.
How financially healthy is CVS HEALTH CORP?
The financial health rating of CVS HEALTH CORP (1CVS.MI) is 3 / 10.
Is the dividend of CVS HEALTH CORP sustainable?
The dividend rating of CVS HEALTH CORP (1CVS.MI) is 6 / 10 and the dividend payout ratio is 192.14%.